The use of tramadol for cancer-associated pain—a systematic review
Relative to other analgesics, tramadol is neither superior nor inferior. There may exist a different safety profile and therefore an opportunity to provide individualized patient-centered treatment strategies focused on safety and quality of life.
Authors
- Elizabeth Pršić (ORCID: https://orcid.org/0000-0003-1364-5599)
- Ronald Chow (ORCID: https://orcid.org/0000-0001-6195-8624)
- Zsuzsanna Németh (ORCID: https://orcid.org/0000-0003-3392-9935)
- Rachel Alexander (ORCID: https://orcid.org/0000-0003-3774-636X)
- Candice Y. Kaminski (ORCID: https://orcid.org/0000-0001-7564-1046)
- Pavan Challa
- Eduardo Bruera
- Shivani Garlapati
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Georgetown University (US)
- University of Toronto (CA)
- MedStar Georgetown University Hospital (US)
- Yale Cancer Center (US)
- University of Oxford (GB)
- Institute of Medical Sciences (IN)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1007/s00520-025-10098-4
- Primary Topic
- Pain Management and Opioid Use
- Type
- article
- Field-Weighted Citation Impact
- 0.00